← Back to headlines
Eli Lilly Stock Under Scrutiny Amid New Drug Developments
Investors are closely monitoring Eli Lilly stock as the company develops new drugs, with particular attention on a key metric that has recently disappeared from reports.
17 Jun, 15:57 — 17 Jun, 15:57
Sources
Showing 1 of 1 sources
